Because FGF9‐induced development of HCC requires a NASH diet, we speculated that additional stimulation induced by the NASH diet is required for the conditions needed for malignant transformation in the liver, such as elevated inflammation, an increased cholesterol level, steatosis and insulin intolerance. Here, FGF9 is linked to metabolic dysfunction-associated steatohepatitis.